Clinical trial
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir…
NCT00275314 · University of Pittsburgh, Other · Terminated
Key facts
| NCT number | NCT00275314 |
|---|---|
| Title | WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients |
| Official title | WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients, Sponsor Protocol Dated 8/11/2005 and Investigator Brochure Version August 2005 |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplant |
| Intervention type | Drug |
| Interventions | Valganciclovir |
| Enrollment | 5 |
| Start date | Feb 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Jan 11, 2006 |
| Last update posted | Dec 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: